Clinical Trials | June 11, 2022
Sanyou Biopharmaceuticals launches Super-Trillion Antibody Libraries
New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets
New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
India is at a key inflexion point of not just ‘Heal in India’ through its vibrant medical value tourism, but also ‘Heal by India’, where our medical professionals can be used to serve not just our country but at the global level.
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
Abevmy follows the launch of the company’s two oncology biosimilars in Canada, Ogivri (bTrastuzumab) in 2019 – the first Trastuzumab approved in the country – and Fulphila (bPegfilgrastim), which was launched in 2020
Globally, cervical cancer is the fourth most common cancer among women, with approximately 30,447 new cases diagnosed in Europe in 2020
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes
Subscribe To Our Newsletter & Stay Updated
